Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.21.1
Condensed Balance Sheets - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Current assets    
Cash $ 757,574 $ 0
Prepaid expenses 1,505,996 6,380
Total current assets 2,263,570 6,380
Deferred offering costs associated with proposed public offering   56,483
Cash held in Trust Account 977,508,835  
Total Assets 979,772,405 62,863
Current liabilities:    
Accounts payable 37,951 23,450
Accrued expenses 359,666 33,033
Due to related party 89,204  
Total current liabilities 486,821 56,483
Deferred legal fees 18,182  
Deferred underwriting commissions 34,212,500  
Derivative warrant liabilities 36,073,540  
Total liabilities 70,791,043 56,483
Commitments and Contingencies
Class A ordinary shares, $0.0001 par value; 90,398,136 and 0 shares subject to possible redemption at $10.00 per share at March 31, 2021 and December 31, 2020, respectively 903,981,360  
Shareholders' Equity:    
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding  
Additional paid-in capital 7,239,434 22,556
Accumulated deficit (2,242,611) (18,620)
Total shareholders' equity 5,000,002 6,380
Total Liabilities and Shareholders' Equity 979,772,405 62,863
Class A Ordinary Shares    
Shareholders' Equity:    
Common Stock 735  
Total shareholders' equity 735 0
Class B Ordinary Shares    
Shareholders' Equity:    
Common Stock 2,444 2,444
Total shareholders' equity $ 2,444 $ 2,444